GB1453234A - Liquid vehicle for pharmaceutical compositions - Google Patents

Liquid vehicle for pharmaceutical compositions

Info

Publication number
GB1453234A
GB1453234A GB1522874A GB1522874A GB1453234A GB 1453234 A GB1453234 A GB 1453234A GB 1522874 A GB1522874 A GB 1522874A GB 1522874 A GB1522874 A GB 1522874A GB 1453234 A GB1453234 A GB 1453234A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
liquid vehicle
glycerine
april
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1522874A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dooner Laboratories Inc
Original Assignee
Dooner Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dooner Laboratories Inc filed Critical Dooner Laboratories Inc
Publication of GB1453234A publication Critical patent/GB1453234A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1453234 Liquid pharmaceutical compositions DOONER LABORATORIES INC 5 April 1974 [5 April 1973] 15228/74 Heading A5B Liquid pharmaceutical compositions comprise theophylline or a therapeutically active salt, complex or derivative thereof, dissolved in a liquid vehicle which comprises propylene glycol, glycerine and water. The compositions may be prepared by suspending the active ingredient in glycerine to form a suspension, dissolving the suspension in propylene glycol and mixing with water. Sodium benzoate. methyl paraben, citric acid, sorbitol, flavouring, dyes and sweetening agents may also be present.
GB1522874A 1973-04-05 1974-04-05 Liquid vehicle for pharmaceutical compositions Expired GB1453234A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US348076A US3928609A (en) 1973-04-05 1973-04-05 Non-alcoholic theophylline product

Publications (1)

Publication Number Publication Date
GB1453234A true GB1453234A (en) 1976-10-20

Family

ID=23366547

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1522874A Expired GB1453234A (en) 1973-04-05 1974-04-05 Liquid vehicle for pharmaceutical compositions

Country Status (8)

Country Link
US (1) US3928609A (en)
JP (1) JPS5427881B2 (en)
AU (1) AU474309B2 (en)
CA (1) CA1029657A (en)
DE (1) DE2416216C2 (en)
FR (1) FR2224160A1 (en)
GB (1) GB1453234A (en)
ZA (1) ZA742156B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2551971A (en) * 2016-06-29 2018-01-10 Syri Ltd Taste masked liquid pharmaceutical composition of (RS)-4-(ethyl[1-(4-methoxyphenyl)propan-2-yl]am ino)butyl 3, 4-dimethoxybenzoate

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH619364A5 (en) * 1976-04-02 1980-09-30 Seebach Adolf Ag
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
FR2531337A1 (en) * 1982-08-04 1984-02-10 Hoechst Lab NEW ORALLY ADMINISTRATIVE GALENIC FORMS, SOLUBLE DIMETHYLXANTHINE DERIVATIVES
ZA853488B (en) * 1984-05-10 1986-12-30 American Home Prod Transdermal dosage form
DE3432112A1 (en) * 1984-08-29 1986-03-13 Asche Ag INJECTION SOLUTION
US5077296A (en) * 1987-12-03 1991-12-31 Hyal Pharmaceutical Corporation Method for treating equine navicular disease with pentoxifylline, and composition containing pentoxifylline for administrating to horses
US5409619A (en) * 1993-08-23 1995-04-25 Reckitt & Colman Inc. Ironing aid composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3109773A (en) * 1961-10-25 1963-11-05 Mead Johnson & Co Bronchodilator expectorant composition containing theophylline and a guaiacol
US3134720A (en) * 1962-06-27 1964-05-26 Bristol Myers Co Medicated gels
US3309271A (en) * 1963-08-30 1967-03-14 Manuf Prod Pharma Methods and composition for inducing choleresis
US3467754A (en) * 1966-08-10 1969-09-16 Mead Johnson & Co Bronchodilator expectorant elixir
US3728346A (en) * 1971-07-16 1973-04-17 Degussa Hydroxyphenylhydroxyalkylaminoalkyltheophyllines

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2551971A (en) * 2016-06-29 2018-01-10 Syri Ltd Taste masked liquid pharmaceutical composition of (RS)-4-(ethyl[1-(4-methoxyphenyl)propan-2-yl]am ino)butyl 3, 4-dimethoxybenzoate
GB2551971B (en) * 2016-06-29 2020-09-16 Syri Ltd Taste masked liquid pharmaceutical composition of mebeverine or pharmaceutically acceptable salts thereof

Also Published As

Publication number Publication date
US3928609A (en) 1975-12-23
CA1029657A (en) 1978-04-18
AU474309B2 (en) 1976-07-15
DE2416216A1 (en) 1974-10-24
FR2224160A1 (en) 1974-10-31
JPS5427881B2 (en) 1979-09-12
JPS505522A (en) 1975-01-21
DE2416216C2 (en) 1984-10-31
ZA742156B (en) 1975-04-30
AU6694174A (en) 1975-09-25

Similar Documents

Publication Publication Date Title
HK52380A (en) Aqueous preparations of dyestuffs or optical brighteners insoluble to difficultly soluble in water as well as the use thereof
ES483894A1 (en) Acid addition salts of 16-beta-monoquaternary ammonium derivatives of 2-beta, 16-beta-bis-piperidino-androstanes and pharmaceutical preparations containing same.
GB1453234A (en) Liquid vehicle for pharmaceutical compositions
AU468994B2 (en) 2,3-DIHYDRO-OXOIMIDAZO [1,2-a] PYRIMIDINES, THEIR ACID ADDITION SALTS THEREOF AND PROCESSES FOR THEIR PREPARATION
CA1034118A (en) Oxamic acid derivatives
AU449293B2 (en) New adenosine-5'carboxylic acid derivatives andthe preparation thereof
CA1013756A (en) Aqueous soluble mixed complex salts of aluminum aliphatic alcohol sulfates
GB1252286A (en)
IE35507B1 (en) Anti-inflammatory preparations containing tetrahydrocarbazole derivatives
IL43927A0 (en) Lysino-calcium chloride and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
IT1016157B (en) CONCENTRATED SOLUTIONS STABLE IN THE STORAGE OF ALKYLBENZOLSULFUR BORN OF BASIC DYES
GB1125349A (en) Soluble salts of ellagic acid
CA1029026A (en) N2-dansyl-l-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof
IL45778A0 (en) Diuretic formulations comprising indanyloxyacetic acid derivatives
GB1431709A (en) Lysozyme derivatives
IE822017L (en) N-methyl-d-glucamine salt
IL45087A (en) Inhalant preparations containing 3,20-dioxo-pregn-4-enoic acid derivatives
IE39401B1 (en) New adrenergic blocking aminopropanols
IL40623A (en) 14,15-dihydro-eburnamine-14-carboxylic acid derivatives and salts thereof,their preparation and pharmaceutical compositions containing them
GB1440849A (en) Cerebral vasodilator compositions
ZA752952B (en) Aqueous preparations of dyestuffs or optical brighteners insoluble to difficultly soluble in water as well as the use thereof
Garfield Ultrastructural aspects of sodium transport in rat myometrium
BE759375A (en) PROCESS FOR THE PREPARATION OF ANTHRAQUINONIC COMPOUNDS LOW SOLUBLE IN WATER
AU464457B2 (en) 6-trichloroacetamido-penicillanic acid derivatives and their preparation
GB1220818A (en) New medicinal composition

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930405